regional anesthesia
Recently Published Documents





2022 ◽  
Vol Publish Ahead of Print ◽  
Michael A. Heffler ◽  
Julia A. Brant ◽  
Amar Singh ◽  
Amanda G. Toney ◽  
Maya Harel-Sterling ◽  

2022 ◽  
Vol 239 ◽  
pp. 151814
Emilio González-Arnay ◽  
Felice Galluccio ◽  
Isabel Pérez-Santos ◽  
Sebastián Merlano-Castellanos ◽  
Elena Bañón-Boulet ◽  

2022 ◽  
Vol 16 (1) ◽  
pp. e01556
Alexander Huynh ◽  
Rabiul Ryan ◽  
Rohan Patel ◽  
Alan Molina ◽  
Alexander M. Olson ◽  

Neurospine ◽  
2021 ◽  
Vol 18 (4) ◽  
pp. 733-740
Jae-Koo Lee ◽  
Jong Hwa Park ◽  
Seung-Jae Hyun ◽  
Daniel Hodel ◽  
Oliver N. Hausmann

This paper is an overview of various features of regional anesthesia (RA) and aims to introduce spine surgeons unfamiliar with RA. RA is commonly used for procedures that involve the lower extremities, perineum, pelvic girdle, or lower abdomen. However, general anesthesia (GA) is preferred and most commonly used for lumbar spine surgery. Spinal anesthesia (SA) and epidural anesthesia (EA) are the most commonly used RA methods, and a combined method of SA and EA (CSE). Compared to GA, RA offers numerous benefits including reduced intraoperative blood loss, arterial and venous thrombosis, pulmonary embolism, perioperative cardiac ischemic incidents, renal failure, hypoxic episodes in the postanesthetic care unit, postoperative morbidity and mortality, and decreased incidence of cognitive dysfunction. In spine surgery, RA is associated with lower pain scores, postoperative nausea and vomiting, positioning injuries, shorter anesthesia time, and higher patient satisfaction. Currently, RA is mostly used in short lumbar spine surgeries. However, recent findings illustrate the possibility of applying RA in spinal tumors and spinal fusion. Various researches reveal that SA is an effective alternative to GA with lower minor complications incidence. Comprehensive insight on RA will promote spine surgery under RA, thereby broadening the horizon of spine surgery under RA.

Folia Medica ◽  
2021 ◽  
Vol 63 (6) ◽  
pp. 913-918
Gabriela Kehayova ◽  
Snezha Zlateva ◽  
Petko Marinov

Introduction: Lipid emulsions are increasingly used as an antidote to lipophilic drug intoxications. The dose recommended by the American Society of Regional Anesthesia is used primarily for the treatment of local anesthetic systemic toxicity. There is insufficient information about what the dose of lipid emulsions (LE) should be in other intoxications depending on their severity. Aim: To determine the LE dose in a shock or haemodynamic instability in patients with acute exogenous intoxications treated with LE. Materials and methods: Forty-nine patients with acute lipophilic drug intoxications were treated with LE in the Clinic of Toxicology at the Naval Hospital in Varna. Statistical analysis was performed using the statistical functions of Excel 2016 and the Statistica 7.0 software package. Results: The percentage of patients receiving a low dose of LE of 0.3 ml/kg (93.87%) was significantly higher than the percentage of patients treated with a medium (2.04%) and a high dose (4.08%) of LF. The high dose of LE of 1.5 ml/kg recommended by the American Society of Regional Anesthesia was administered to two patients (4.08%). In severe intoxications with exotoxic shock, the rate of LE administration varies from 20 ml/h to 40 ml/h. Conclusions: In severe intoxications with cardiotoxic syndrome and haemodynamic instability, LE should be used in the dose as suggested by the American Society of Regional Anesthesia. It is possible to use lower doses of LE in the range of 0.3–0.6 ml/kg in all moderate poisonings administered by continuous intravenous infusion for 12-24-48 hours. No side effects were observed at these doses.

Sign in / Sign up

Export Citation Format

Share Document